TP53 and pituitary adenocarcinoma: In a clinicopathologic study of 15 cases of pituitary carcinoma, Pernicone et al. [4] demonstrated an increase in the percentage of nuclear staining for p53 oncoprotein in pituitary metastases (mean, 7.3%) as compared with solitary pituitary adenomas (mean, 1%).